| 4/9/2008 |
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD |
| |
Ferring Pharmaceuticals Announces 2008 My Little Miracle Essay Contest... |
| 4/18/2007 |
FERRING REPORTS ON ENDOMETRIN� PRESENTATIONS AT PACIFIC COAST REPRODUCTIVE SOCIETY ANNUAL MEETING |
| |
Progesterone Vaginal Supplement Studied in Largest-Ever IVF Trial in US... |
| 6/7/2006 |
COMPARATIVE STUDY SHOWS SAFER, MORE CONTROLLED STIMULATION WITH MENOPUR® THAN GONAL-f® IN OVULATION INDUCTION |
| |
LH-Modified Follicular Development Could Improve Safety in OI and Lower Risk of Multiple Pregnancies... |
| 5/30/2006 |
NATIONWIDE SURVEY FINDS ONLY 30 PERCENT OF PATIENTS UNDERGOING INFERTILITY TREATMENT ARE ABLE TO ADMINISTER THEIR MEDICATIONS WITH ONE INJECTION PER DAY |
| |
Infertility Treatments Remain Complex and Anxiety-Producing for Many... |
| 4/10/2006 |
FERRING PHARMACEUTICALS ANNOUNCES EUFLEXXA™ LABELING EXTENDED TO INCLUDE ROOM TEMPERATURE STORAGE |
| |
Ferring Debuts New Product Labeling at AAOS Annual Meeting... |
| 2/27/2006 |
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD |
| |
Ferring Pharmaceuticals Announces 2006 My Little Miracle Essay Contest... |
| 2/14/2006 |
FERRING PHARMACEUTICALS ANNOUNCES BRUCE JENNER AS NATIONAL SPOKESPERSON FOR EUFLEXXA™ |
| |
Olympic Gold Medal Winner is First in the U.S. to be Treated with EUFLEXXA™... |
| 2/14/2006 |
HEAD-TO-HEAD STUDY SHOWS EUFLEXXA™ HAS GREATER TOLERABILITY COMPARED TO SYNVISC® FOR OSTEOARTHRITIS KNEE PAIN |
| |
Significantly More Patients Symptom-Free, Lower Incidence of Joint Effusions... |
| 11/14/2005 |
FERRING PHARMACEUTICALS ANNOUNCES LAUNCH OF EUFLEXXA™ FOR OSTEOARTHRITIS KNEE PAIN |
| |
More Patients Treated with EUFLEXXA™ Symptom-Free at End of 12-Week Study Than... |
| 7/19/2005 |
FERRING PHARMACEUTICALS OBTAINS RIGHTS TO EUFLEXXA™ |
| |
Enters Co-Promotion Agreement with Savient... |
| 5/20/2005 |
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD |
| |
Ferring Pharmaceuticals Announces 2005 My Little Miracle Essay Contest... |
| 5/11/2005 |
FERRING PHARMACEUTICALS APPOINTS OLIVIER DELANNOY AS
VICE PRESIDENT, INFERTILITY BUSINESS UNIT |
| |
Suffern, NY – May 11, 2005 – Ferring Pharmaceuticals Inc. announced that Olivier A. Delannoy has been appointed vice president, Infertility Business Unit.... |
| 5/11/2005 |
FERRING PHARMACEUTICALS APPOINTS WILLIAM GARBARINI AS
SENIOR DIRECTOR OF MARKETING |
| |
Responsible for Marketing for Newly Created Orthopedics/Urology Business Unit... |
| 4/11/2005 |
FERRING PHARMACEUTICALS ANNOUNCES LAUNCH OF NEW TREATMENT
FOR INFERTILITY |
| |
MENOPUR® (menotropins for injection, USP) First Gonadotropin to Receive FDA Approval Based on Pregnancy Rates... |
| 1/11/2005 |
MICHAEL SECKLER APPOINTED NATIONAL SALES DIRECTOR FOR FERRING PHARMACEUTICALS |
| |
Suffern, NY – January 11, 2005 – Ferring Pharmaceuticals announced today the appointment of Michael Seckler, of Warren, NJ, to national sales director.... |
| 12/10/2004 |
LOCAL WOMAN WINS $1,000 FOR HER 19-MONTH-OLD SON |
| |
Monroe Resident Wins Honorable Mention Prize for Ferring’s My Little Miracle Essay Contest... |
| 12/10/2004 |
FAMILY BEGINNINGS CELEBRATES WITH ITS PATIENTS NAMED AS WINNERS OF FERRING’S MY LITTLE MIRACLE ESSAY CONTEST |
| |
Ferring Presents $3,000 in Prizes to Honorable Mention Winners... |
| 12/10/2004 |
OAK BROOK FERTILITY CELEBRATES WITH ITS PATIENT NAMED AS WINNER OF FERRING’S MY LITTLE MIRACLE ESSAY CONTEST |
| |
Ferring Presents $1,000 to Local Honorable Mention Winner... |
| 12/10/2004 |
LOCAL MAN WINS $5,000 FOR HIS 11-MONTH-OLD CHILDREN |
| |
Northville Resident Wins Runner-Up Prize in Ferring’s My Little Miracle Essay Contest... |
| 12/10/2004 |
GEORGIA REPRODUCTIVE SPECIALISTS CELEBRATES WITH ITS PATIENT NAMED AS WINNER OF FERRING’S MY LITTLE MIRACLE ESSAY CONTEST |
| |
Ferring Presents $1,000 to Local Honorable Mention Winner... |
| 12/8/2004 |
LOCAL FERTILITY PRACTICE CELEBRATES PATIENT NAMED AS WINNER OF FERRING’S MY LITTLE MIRACLE ESSAY CONTEST |
| |
Ferring Presents $1,000 to Honorable Mention Winner... |
| 10/18/2004 |
FERRING SUPPORTS SYMPOSIUM ON OPTIMIZING ASSISTED REPRODUCTIVE TECHNOLOGY (ART) |
| |
Held at 60th Annual Meeting of the American Society for Reproductive Medicine... |
| 10/18/2004 |
FERRING INTRODUCES BRAVELLE® WITH FIRST NEEDLE-FREE RECONSTITUTION DEVICE |
| |
Q·Cap™ Previewed at Annual ASRM Meeting... |
| 10/18/2004 |
SOCIETY FOR REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY ANNOUNCES FERRING PHARMACEUTICALS' SPONSORSHIP OF FELLOWS' RETREAT 2005-2007 |
| |
The Society for Reproductive Endocrinology and Infertility (SREI) announced today that Ferring Pharmaceuticals will be the new sponsor of its annual educational Fellows' Retreat Program from 2005 through 2007.... |
| 10/18/2004 |
FERRING PRESENTS $10,000 GRAND PRIZE TO WINNER OF MY LITTLE MIRACLE ESSAY CONTEST |
| |
Contest Winner Announced at ASRM... |
| 7/21/2004 |
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD |
| |
Ferring Pharmaceuticals Announces My Little Miracle Essay Contest... |
| 4/28/2004 |
RESULTS OF EMBRACE* TRIALS PRESENTED AT THE PACIFIC COAST REPRODUCTIVE SOCIETY MEETING |
| |
Rancho Mirage, CA -- April 28, 2003 -- Results of clinical trials evaluating the combined use of two human-derived infertility treatments in in vitro fertilization (IVF) ... |
| 2/10/2003 |
CLINICAL STUDY CONFIRMS EFFECTIVENESS OF FERRING’S NEW BRAVELLE® IN PRODUCING DONOR EGGS FOR IVF |
| |
SUFFERN, NY – February 10, 2003 – According to a new study published in the First Quarter 2003 issue of Today’s Therapeutic Trends, Bravelle® ... |
| 12/19/2002 |
FDA APPROVES BRAVELLE™ FOR IN VITRO FERTILIZATION |
| |
SUFFERN, NY – December 19, 2002 – Ferring Pharmaceuticals' new infertility treatment Bravelle™ (urofollitropin for injection, purified), approved by the U.S. Food and Drug Administration (FDA) for ovulation induction... |
| 11/11/2002 |
THE AMERICAN INFERTILITY ASSOCIATION, RESOLVE AND FERRING TEAM UP TO IMPROVE ACCESS TO INFERTILITY TREATMENT |
| |
TARRYTOWN, NY – November 11, 2002 – Ferring Pharmaceuticals, The American Infertility Association (AIA) and RESOLVE: The National Infertility Association today announced the launch of the Bravelle™ HEART Program. The Bravelle™... |
| 6/10/2002 |
CLINICAL STUDY SUPPORTS IVF INDICATION FOR FERRING’S NEW BRAVELLE™ (urofollitropin for injection, purified) |
| |
TARRYTOWN, NY – June 10, 2002 – According to a new study published in the June issue of Fertility and Sterility, Bravelle™ (urofollitropin for injection, purified), a highly purified human-derived follicle-stimulating hormone (hFSH), administered... |
| 5/6/2002 |
FDA APPROVES BRAVELLE™ (urofollitropin for injection, purified) FERRING’S NEW HUMAN-DERIVED FOLLICLE-STIMULATING HORMONE FOR INFERTILITY TREATMENT |
| |
TARRYTOWN, NY – May 6, 2002 – Ferring Pharmaceuticals, a world leader in naturally occurring protein hormones, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Bravelle™ (urofollitropin for injection... |
| 4/29/2002 |
FERRING PHARMACEUTICALS PRESENTS DATA ON NEW INFERTILITY TREATMENTS AT THE PACIFIC COAST REPRODUCTIVE SOCIETY MEETING |
| |
Rancho Las Palmas, CA – April 22, 2002 -- Results of clinical trials evaluating Ferring Pharmaceuticals’ infertility treatments-- a human-derived follicle stimulating hormone (hFSH) and a purified human menopausal gonadotropin (hMG), which are currently u... |
| 10/24/2001 |
FERRING PHARMACEUTICALS LAUNCHES NEW WEB SITE OFFERING INFORMATION ON INFERTILITY TREATMENT |
| |
ORLANDO, FL - October 24, 2001 - Ferring Pharmaceuticals announced today the launch of a new Web site that provides both consumers and professionals with comprehensive information on infertility and its treatment. The new site, www.ferringfertility.com... |
| 10/24/2001 |
FERRING PHARMACEUTICALS HONORED BY THE AMERICAN INFERTILITY ASSOCIATION |
| |
NEW YORK - October 24, 2001 -- Ferring Pharmaceuticals, an international biopharmaceutical company that specializes in infertility treatments, received a... |
| 2/28/2001 |
FERRING INITIATES LANDMARK CLINICAL TRIALS TO EVALUATE OPTIMAL DRUG PROTOCOL FOR IVF TREATMENT |
| |
Tarrytown, NY, February 28, 2001 -- Ferring Pharmaceuticals, which specializes in human-derived hormones for infertility treatment, is conducting two clinical trials to investigate the optimal dose and ratio of two hormones used to stimula... |
